Novel targeted therapy shows promise to eliminate leukaemia stem cells

WASHINGTON - A piece of research has shown that it is possible to eliminate stem cells related to human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer, using a new targeted therapy. Associate Professor Richard Lock, from the Children’s Cancer Institute Australia and the University of New South Wales, has revealed that the new therapeutic [...]

Read this article...